RHEJOICE (RHubarb Root Menopause Relief) "Rejoice"

RHEJOICE (RHubarb Root Menopause Relief) "Rejoice"Clinical Applications Designed to Support Women During Hormonal Transitions Supports Healthy Hormone Balance Maintains Normal Inflammatory Balance Supports Positive Mood Menopause is a natural and transformative phase in a womans life, typically occurring in the late 40s or early 50s. Hormonal shifts, marked by a decline in estrogen and progesterone, lead to various common symptoms such as hot flashes, night sweats, mood swings, physical and mental

Clinical Applications

• Designed to Support Women During Hormonal Transitions
• Supports Healthy Hormone Balance
• Maintains Normal Inflammatory Balance
• Supports Positive Mood

Menopause is a natural and transformative phase in a woman’s life, typically occurring in the late 40s or early 50s. Hormonal shifts, marked by a decline in estrogen and progesterone, lead to various common symptoms such as hot flashes, night sweats, mood swings, physical and mental fatigue, sexual frustration, and sleep disturbances. The onset of these symptoms commonly begins several years before menopause and persists for up to 5 years after, significantly affecting daily life and overall wellbeing. By harnessing the researched benefits of rhapontic rhubarb root extract (ERR), RHEJOICE specifically addresses hormone balance, maintains a normal inflammatory balance, and provides antioxidant support to help women navigate the challenges of menopause with greater ease and wellbeing.

RHEJOICE  "Rejoice" is a specialized formula designed to address the diverse facets of menopause.

Suggested Use:

1 capsule per day or as recommended by your health care professional.

Benefits:

Rhapontic Rhubarb Root Extract (ERR)

ERR is a phytoestrogen extract derived from the roots of rhapontic rhubarb (Rheum rhaponticum L.) and is recognized in scientific literature as a solution for menopausal complaints. Specifically, ERR functions as a selective estrogen receptor modulator (SERM). This means that it selectively targets estrogen receptor β (ERβ) in the body without affecting estrogen receptor α (ERα). This specificity is documented in in-vitro studies and is crucial because it allows ERR to deliver its benefits in addressing menopausal symptoms without influencing other estrogen receptors in the body.